Old Web
English
Sign In
Acemap
>
authorDetail
>
S.M. Leland
S.M. Leland
Seribantumab
Monoclonal antibody
Molecular biology
Cell culture
Chemistry
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MO01.33 CRESTONE – Clinical Study of REsponse to Seribantumab in Tumors with NEuregulin-1 (NRG1) Fusions – A Phase 2 Study of the anti-HER3 mAb for Advanced or Metastatic Solid Tumors (NCT04383210)
2021
Journal of Thoracic Oncology
David R. Spigel
Saiama N. Waqar
Mark E. Burkard
Jessica J. Lin
Young Kwang Chae
Mark A. Socinski
S. M. Gadgeel
Karen L. Reckamp
S.M. Leland
D. Plessinger
L. Kunkel
Jessica Ruth Bauman
G Otterson
Balazs Halmos
S.-H. Ignatius Ou
Tejas Patil
Yasir Elamin
Edward S. Kim
Show All
Source
Cite
Save
Citations (0)
The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements
2020
European Journal of Cancer
Igor Odintsov
Eric Gladstone
W.J. Sisso
Lukas Delasos
Allan J.W. Lui
E.M. Sisso
Morana Vojnic
Inna Khodos
Marissa Mattar
E. de Stanchina
D. Plessinger
S.M. Leland
M. Ladanyi
Romel Somwar
Show All
Source
Cite
Save
Citations (0)
1